Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2012Disease Models & MechanismsOpen Access

Anti-obesity drugs: past, present and future

View Full Paper
Ask AI
Bookmark
Share

Authors

RRR.J. RodgersCreative Victoria
Matthias H. Tschöp
Matthias H. TschöpCincinnati Children's Hospital Medical Center
John Wilding
John WildingUniversity of Liverpool

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rodgers et al. (2012) studied this question.

synapsesocial.com/papers/6a7e4c26b44705ee46856820https://doi.org/10.1242/dmm.009621
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Amylin-Mediated Restoration of Leptin Responsiveness in Diet-Induced Obesity: Magnitude and Mechanisms2008 · 151 citations
  2. 2Hydroxychloroquine and Risk of Diabetes in Patients With Rheumatoid Arthritis2007 · 293 citations
  3. 3The utility of animal models to evaluate novel anti‐obesity agents2011 · 108 citations